658 related articles for article (PubMed ID: 27658674)
1. Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia.
Bordia T; Zhang D; Perez XA; Quik M
Exp Neurol; 2016 Dec; 286():32-39. PubMed ID: 27658674
[TBL] [Abstract][Full Text] [Related]
2. Neostriatal GABAergic Interneurons Mediate Cholinergic Inhibition of Spiny Projection Neurons.
Faust TW; Assous M; Tepper JM; Koós T
J Neurosci; 2016 Sep; 36(36):9505-11. PubMed ID: 27605623
[TBL] [Abstract][Full Text] [Related]
3. Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesias.
Bordia T; Perez XA; Heiss J; Zhang D; Quik M
Neurobiol Dis; 2016 Jul; 91():47-58. PubMed ID: 26921469
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M
J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457
[TBL] [Abstract][Full Text] [Related]
5. Effects of haloperidol on cholinergic striatal interneurons: relationship to oral dyskinesias.
Kelley JJ; Roberts RC
J Neural Transm (Vienna); 2004 Aug; 111(8):1075-91. PubMed ID: 15254795
[TBL] [Abstract][Full Text] [Related]
6. Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia.
Lister J; Andreazza AC; Navaid B; Wilson VS; Teo C; Nesarajah Y; Wilson AA; Nobrega JN; Fletcher PJ; Remington G
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jan; 72():23-29. PubMed ID: 27565433
[TBL] [Abstract][Full Text] [Related]
7. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
[TBL] [Abstract][Full Text] [Related]
8. Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice.
Perez XA; Zhang D; Bordia T; Quik M
Mov Disord; 2017 Apr; 32(4):538-548. PubMed ID: 28256010
[TBL] [Abstract][Full Text] [Related]
9. Whole-brain mapping of inputs to projection neurons and cholinergic interneurons in the dorsal striatum.
Guo Q; Wang D; He X; Feng Q; Lin R; Xu F; Fu L; Luo M
PLoS One; 2015; 10(4):e0123381. PubMed ID: 25830919
[TBL] [Abstract][Full Text] [Related]
10. Homeostatic regulation of excitatory synapses on striatal medium spiny neurons expressing the D2 dopamine receptor.
Thibault D; Giguère N; Loustalot F; Bourque MJ; Ducrot C; El Mestikawy S; Trudeau LÉ
Brain Struct Funct; 2016 May; 221(4):2093-107. PubMed ID: 25782435
[TBL] [Abstract][Full Text] [Related]
11. Novel fast adapting interneurons mediate cholinergic-induced fast GABAA inhibitory postsynaptic currents in striatal spiny neurons.
Faust TW; Assous M; Shah F; Tepper JM; Koós T
Eur J Neurosci; 2015 Jul; 42(2):1764-74. PubMed ID: 25865337
[TBL] [Abstract][Full Text] [Related]
12. Haloperidol-Induced Preclinical Tardive Dyskinesia Model in Rats.
Guzen FP; Cavalcanti JRLP; Cavalcanti DMLP; de Sales LGP; da Silva MSM; da Silva ANA; Pinheiro FI; de Araújo DP
Curr Protoc Neurosci; 2019 Jun; 88(1):e68. PubMed ID: 31216395
[TBL] [Abstract][Full Text] [Related]
13. Parallels between behavioral and neurochemical variability in the rat vacuous chewing movement model of tardive dyskinesia.
Bachus SE; Yang E; McCloskey SS; Minton JN
Behav Brain Res; 2012 Jun; 231(2):323-36. PubMed ID: 22503783
[TBL] [Abstract][Full Text] [Related]
14. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.
Suárez LM; Solís O; Caramés JM; Taravini IR; Solís JM; Murer MG; Moratalla R
Biol Psychiatry; 2014 May; 75(9):711-22. PubMed ID: 23769604
[TBL] [Abstract][Full Text] [Related]
15. Nicotine reduces antipsychotic-induced orofacial dyskinesia in rats.
Bordia T; McIntosh JM; Quik M
J Pharmacol Exp Ther; 2012 Mar; 340(3):612-9. PubMed ID: 22144565
[TBL] [Abstract][Full Text] [Related]
16. Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide.
Naidu PS; Kulkarni SK
Behav Pharmacol; 2001 Jun; 12(3):209-16. PubMed ID: 11485057
[TBL] [Abstract][Full Text] [Related]
17. Ginkgo biloba and vitamin E ameliorate haloperidol-induced vacuous chewingmovement and brain-derived neurotrophic factor expression in a rat tardive dyskinesia model.
Shi J; Tan YL; Wang ZR; An HM; Li J; Wang YC; Lv MH; Yan SX; Wu JQ; Soares JC; Yang FD; Zhang XY
Pharmacol Biochem Behav; 2016 Sep; 148():53-8. PubMed ID: 27264436
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
Wei W; Ding S; Zhou FM
J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.
Egan MF; Hurd Y; Ferguson J; Bachus SE; Hamid EH; Hyde TM
Psychopharmacology (Berl); 1996 Oct; 127(4):337-45. PubMed ID: 8923569
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARγ receptors.
Sonego AB; Prado DS; Vale GT; Sepulveda-Diaz JE; Cunha TM; Tirapelli CR; Del Bel EA; Raisman-Vozari R; Guimarães FS
Brain Behav Immun; 2018 Nov; 74():241-251. PubMed ID: 30217539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
